GL1X · GenesisL1 explorer

Research workbench

Engineered human lipocalin 2 (LCN2) in complex with the extracellular domain of human ctla-4

Analyse Engineered human lipocalin 2 (LCN2) in complex with the extracellular domain of… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3BX7
Type
protein
Length
293 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cytotoxic T-lymphocyte-associated antigen 4; Engineered human lipocalin 2
UniProt
P16410
Pockets
1 · best druggability 0.57

Structure

x-ray diffraction · 2 distinct chains · 10% helix, 46% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
CCytotoxic T-lymphocyte-associated antigen 4protein1203% helix, 52% strandP16410
AEngineered human lipocalin 2protein17315% helix, 42% strand—

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12120.570.7934empty

Interfaces

1 interface between chains.

  • C–A · 1235 Ų buried · 18 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 3 disulfide (disulfide).

Compared structures

  • 3BX7 · Engineered Human Lipocalin 2 (LCN2) in Complex with the Extracellular Domain of Human… · the same entry in another collection · chain A against A, TM-score 1.00
  • P16410 · AlphaFold monomer V2.0 prediction for cytotoxic T-lymphocyte protein 4 (P16410) · a predicted model of the same protein · chain C against A, TM-score 0.91

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.